EUVIMEDEUVIMED entdecken
Crossref

Factors Affecting the Success of Sphenopalatine Artery Ligation in the Management of Intractable Epistaxis—A Single-Centered Retrospective Analysis

Joseph Latif iD, Emma Ho, Jordan Fuzi, Catherine Banks iD

American Journal of Rhinology & Allergy · 2026

DOI: 10.1177/19458924251372241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Rhinology & Allergy, 2026. Verfasst von Joseph Latif und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head & Neck Surgery, Prince of Wales Hospital, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Epistaxis, Endoscopy, Arteries. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endoscopic sphenopalatine artery ligation (ESPAL) is a safe and effective procedure to manage intractable epistaxis. However, in the literature, the peri-operative and patient factors which contribute to surgical success or failure have been poorly defined.

Objective

The purpose of this study was to identify the patient, disease and surgical factors which influence the effectiveness of ESPAL in the management of intractable epistaxis.

Methods

All ESPALs performed over a 14-year period at a single tertiary otolaryngology department to manage epistaxis refractory to conservative management were retrospectively analyzed. Recurrence of epistaxis was defined as any patient who presented to an emergency department with epistaxis on the same side as their previous ESPAL at any time post-operatively. Subjects were grouped as either a non-recurrence or recurrence group.

Results

40 patients underwent ESPAL to treat intractable epistaxis. Anticoagulation, smoking, and active malignancy were associated with higher rates of recurrence after ESPAL ( P < .05). The recurrence rate was 20% with an average follow-up period of 5 years. The average time between ESPAL and epistaxis recurrence was 10 days. 50% (n = 4) of patients with recurrence required escalation to endovascular embolization. No patients had recurrence of epistaxis following additional radiological intervention.

Conclusion

One in five patients experienced a recurrence in epistaxis following ESPAL within 3 weeks of their surgery. Smokers, patients on anticoagulation and patients with malignancy are more likely to experience recurrence. If re-presenting with epistaxis following ESPAL, patients are likely to require radiological intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpistaxisEndoscopyArteriesHumansLigationRetrospective StudiesMaleFemaleMiddle AgedAgedRecurrenceTreatment OutcomeAdultAged, 80 and overEmbolization, TherapeuticFollow-Up Studies

Stichwörter der Autor:innen

blood thinnersembolizationendoscopic ligationepistaxisnosebleedsrebleedingrecurrencerefractory epistaxissphenopalatine arterysurgical management of epistaxis

Autor:innen und Institutionen

  • Department of Otolaryngology, Head & Neck Surgery, Prince of Wales Hospital, Sydney, NSW, Australia.

ORCID-Profile: Joseph Latif, Catherine Banks

Zitieren

APA

Latif, J., Ho, E., Fuzi, J., & Banks, C. (2026). Factors Affecting the Success of Sphenopalatine Artery Ligation in the Management of Intractable Epistaxis—A Single-Centered Retrospective Analysis. American Journal of Rhinology & Allergy. https://doi.org/10.1177/19458924251372241

Vancouver

Latif J, Ho E, Fuzi J, Banks C. Factors Affecting the Success of Sphenopalatine Artery Ligation in the Management of Intractable Epistaxis—A Single-Centered Retrospective Analysis. American Journal of Rhinology & Allergy. 2026. doi:10.1177/19458924251372241

BibTeX
@article{Latif2026,
  author = {Latif, Joseph and Ho, Emma and Fuzi, Jordan and Banks, Catherine},
  title = {Factors Affecting the Success of Sphenopalatine Artery Ligation in the Management of Intractable Epistaxis—A Single-Centered Retrospective Analysis},
  journal = {American Journal of Rhinology & Allergy},
  year = {2026},
  doi = {10.1177/19458924251372241}
}
Kostenlos starten →